Pharmaconsult SRL
Pharmaconsult reported total assets of 669,769 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Mar 2026).
The score of Pharmaconsult shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +18 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmaconsult's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 5,843 € | ||||
| Equity | 286,815 € | ||||
| Cash | 156,614 € | ||||
| EBITDA | 75,310 € | ||||
| Total assets | 669,769 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 23 Mar 2026
- Year ended 30 Sep 2024filed on 17 Mar 2025
- Year ended 30 Sep 2023filed on 15 Dec 2023
- Year ended 30 Sep 2022filed on 01 Apr 2023
- Year ended 30 Sep 2021filed on 30 Mar 2022
Pharmaconsult's financial analysis
- Solvency42.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmaconsult
Pharmaconsult's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0508.581.589
- VAT number
- BE0508581589
- Peppol
- Registered · 0208:0508581589 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Dec 2012
- Registered office
- 3582 Beringen
- Latest accounts
- 2025 · filed on 23 Mar 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmaconsult (SRL) has been based in Beringen since 2012, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 5,843 € and equity of 286,815 €; its revenue is not published. Its solvency stands at 42.8%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmaconsult
Companies in the same business, of comparable size and area, outside its group.
- T.Lamote Retail sale of pharmaceutical products Merchtem · balance sheet 663,074 €
- Apotheek Legrand Retail sale of pharmaceutical products Zonnebeke · balance sheet 669,625 €
- Pharmacie Beneux Retail sale of pharmaceutical products Ans · balance sheet 669,914 €
- Gremaster Retail sale of pharmaceutical products Ronse · balance sheet 670,030 €
- Merelbeke Farma Retail sale of pharmaceutical products Merelbeke-Melle · balance sheet 670,499 €
- GDK Pharmacy Retail sale of pharmaceutical products Grimbergen · balance sheet 668,691 €
- Apoteek G. en J. Bijnens Retail sale of pharmaceutical products Genk · balance sheet 674,078 €
- Financiere Delhaye Retail sale of pharmaceutical products Forest · balance sheet 674,523 €
Frequently asked questions about Pharmaconsult
What is the revenue of Pharmaconsult?
Pharmaconsult files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmaconsult?
In Belgium, the VAT number is the company number prefixed with BE: BE0508581589 for Pharmaconsult, if the company is VAT-registered. Its company number (CBE) is 0508.581.589.
Where is the registered office of Pharmaconsult?
According to the CBE register, the registered office of Pharmaconsult is in 3582 Beringen.
What is the equity of Pharmaconsult?
At the close of the 2025 financial year, the equity of Pharmaconsult amounts to 286,815 €, a solvency of 42.8% of total assets.
Who manages Pharmaconsult?
The register lists 2 active mandates at Pharmaconsult. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmaconsult
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →